Vancouver, British Columbia–(Newsfile Corp. – June 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“ Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce the addition of emergency physician and addiction specialist, Dr. Dinesh Bayana as a medical advisor, providing expertise on the…


Previous articleWhat Is Transpersonal Psychology and How Does It Relate to Psychedelics?
Next articlePT251 – Kristina & Jonas of the Psychedelic Literacy Fund – Celebrating Stan Grof